|
CFO/Company Secretary Appointment
|
16 June 2023 at 9:15am
|
|
Quarterly update and Appendix 4C
|
28 April 2023 at 9:20am
|
|
Company Secretary/CFO Appointment/Resignation
|
21 March 2023 at 9:35am
|
|
Investor Presentation
|
14 March 2023 at 1:05pm
|
|
Change of Director's Interest Notice
|
1 March 2023 at 10:05am
|
|
Half Yearly Report and Accounts
|
22 February 2023 at 3:40pm
|
|
Investor presentation
|
2 February 2023 at 12:10pm
|
|
Quarterly update and Appendix 4C
|
30 January 2023 at 11:20am
|
|
Notification of cessation of securities - GSS
|
11 January 2023 at 2:40pm
|
|
Investor webinar presentation
|
9 December 2022 at 12:20pm
|
|
Change of Director's Interest Notice
|
18 November 2022 at 3:30pm
|
|
Notification regarding unquoted securities - GSS
|
18 November 2022 at 3:30pm
|
|
Results of Meeting
|
16 November 2022 at 1:40pm
|
|
Chairman's Address to Shareholders & CEO Presentation
|
16 November 2022 at 10:30am
|
|
Change of Registry Address
|
31 October 2022 at 4:30pm
|
|
Notification regarding unquoted securities - GSS
|
27 October 2022 at 4:10pm
|
|
Notification of cessation of securities - GSS
|
27 October 2022 at 4:10pm
|
|
Application for quotation of securities - GSS
|
27 October 2022 at 4:00pm
|
|
Quarterly update and Appendix 4C
|
27 October 2022 at 9:50am
|
|
Investor presentation
|
18 October 2022 at 10:30am
|
|
Notice of Annual General Meeting/Proxy Form
|
14 October 2022 at 10:25am
|
|
Response to ASX Query
|
3 October 2022 at 4:30pm
|
|
Appendix 4G and Corporate Governance Statement
|
30 September 2022 at 11:20am
|
|
Annual Report to shareholders
|
30 September 2022 at 10:55am
|
|
3base Kit for Antimicrobial Resistance Shows High Detection
|
29 September 2022 at 9:50am
|
|
Investor presentation
|
7 September 2022 at 8:40am
|
|
Full Year Statutory Accounts
|
31 August 2022 at 3:45pm
|
|
Quarterly update and Appendix 4C
|
27 July 2022 at 10:45am
|
|
Clinical trial recruitment completed for US enteric kit
|
26 July 2022 at 12:05pm
|
|
Notification of cessation of securities - GSS
|
13 May 2022 at 1:00pm
|
|
Application for quotation of securities - GSS
|
13 May 2022 at 1:00pm
|
|
Initial Director's Interest Notice
|
13 May 2022 at 11:15am
|
|
Director Appointment
|
13 May 2022 at 10:15am
|
|
Notification of cessation of securities - GSS
|
3 May 2022 at 4:10pm
|
|
Application for quotation of securities - GSS
|
3 May 2022 at 4:10pm
|
|
Investor presentation
|
27 April 2022 at 8:35am
|
|
Quarterly update and Appendix 4C
|
26 April 2022 at 9:40am
|
|
Application for quotation of securities - GSS
|
12 April 2022 at 4:00pm
|
|
Public Health Wales Awards Enteric Testing Contract to GSS
|
30 March 2022 at 9:20am
|
|
S&P DJI Announces March 2022 Quarterly Rebalance
|
4 March 2022 at 5:30pm
|
|
Company presentation
|
18 February 2022 at 12:00pm
|
|
Half Yearly Report and Accounts
|
18 February 2022 at 9:25am
|
|
Investor webinar presentation
|
17 February 2022 at 9:55am
|
|
Application for quotation of securities - GSS
|
1 February 2022 at 4:55pm
|
|
Investor presentation
|
28 January 2022 at 11:30am
|
|
Quarterly update and Appendix 4C
|
21 January 2022 at 9:50am
|
|
Application for quotation of securities - GSS
|
20 January 2022 at 3:50pm
|
|
3base SARS-CoV-2 kit registered by TGA for saliva samples
|
10 January 2022 at 10:55am
|
|
Investor update
|
21 December 2021 at 12:50pm
|
|
Change of Director's Interest Notice
|
22 November 2021 at 4:10pm
|
